Literature DB >> 9003016

Müllerian inhibiting substance inhibits branching morphogenesis and induces apoptosis in fetal rat lung.

E A Catlin1, V C Tonnu, R G Ebb, B A Pacheco, T F Manganaro, R M Ezzell, P K Donahoe, J Teixeira.   

Abstract

Müllerian inhibiting substance (MIS) is a glycoprotein hormone required for normal male reproductive tract development; it is presumed to signal through a heteromeric complex of type I and type II receptors. MIS exposure produces a paracrine-mediated regression of the embryonic Müllerian duct with histological changes consistent with apoptosis. MIS has also been shown to inhibit fetal lung development in vitro and in vivo, although the mechanism of this inhibition is unknown. The primordial lung and gonad are anatomically proximate on embryonic day 13.5, raising the possibility of a paracrine-mediated influence of MIS in male embryos on lung as well as MIS effecting dissolution of the Müllerian duct. We hypothesized that a negative regulatory event(s) might occur in the lung, as occurs in the duct, at the onset of MIS protein expression; thus, apoptosis and branching morphogenesis were studied in explanted fetal rat lungs incubated with proteolytically activated MIS. MIS exposure resulted in reduced total lung bud number as well as lung perimeter length. Explanted lungs exposed to MIS also exhibited numerous apoptotic bodies. To assess whether this MIS-induced phenomenon in lung might be mediated by the MIS type II receptor (MIS RII), reverse transcriptase-PCR performed on multiple fetal rat lung RNA samples using oligonucleotide primers designed from the 3'-untranslated region of rat MIS RII complementary DNA showed a product of the expected size that when sequenced was nearly identical to rat MIS RII. Northern blot analysis using polyadenylated fetal rat lung RNA and a 3'-MIS RII probe revealed a 2-kilobase transcript that was also seen in testicular messenger RNA. These studies show that the putative ligand binding receptor for MIS is expressed in embryonic lung, where MIS negatively modulates branching and activates apoptosis. We speculate that the mechanism of MIS-induced inhibition of lung development in the male fetus begins with MIS binding to the MIS RII, followed by a signaling cascade resulting in delayed airway branching temporally associated with enhanced apoptosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9003016     DOI: 10.1210/endo.138.2.4906

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  8 in total

1.  Anti-Müllerian Hormone Signaling Regulates Epithelial Plasticity and Chemoresistance in Lung Cancer.

Authors:  Tim N Beck; Vladislav A Korobeynikov; Alexander E Kudinov; Rachel Georgopoulos; Nehal R Solanki; Magda Andrews-Hoke; Timothy M Kistner; David Pépin; Patricia K Donahoe; Emmanuelle Nicolas; Margret B Einarson; Yan Zhou; Yanis Boumber; David A Proia; Ilya G Serebriiskii; Erica A Golemis
Journal:  Cell Rep       Date:  2016-07-07       Impact factor: 9.423

2.  A novel in vitro model to study alveologenesis.

Authors:  Alberto C Pieretti; Alwiya M Ahmed; Jesse D Roberts; Cassandra M Kelleher
Journal:  Am J Respir Cell Mol Biol       Date:  2014-02       Impact factor: 6.914

3.  Patterns of Müllerian Inhibiting Substance Type II and Candidate Type I Receptors in Epithelial Ovarian Cancer.

Authors:  E Basal; T Ayeni; Q Zhang; C Langstraat; P K Donahoe; D Pepin; X Yin; E Leof; W Cliby
Journal:  Curr Mol Med       Date:  2016       Impact factor: 2.222

Review 4.  TGF-β Family Signaling in Ductal Differentiation and Branching Morphogenesis.

Authors:  Kaoru Kahata; Varun Maturi; Aristidis Moustakas
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-03-01       Impact factor: 10.005

5.  Mullerian-inhibiting substance regulates NF-kappa B signaling in the prostate in vitro and in vivo.

Authors:  Dorry L Segev; Yasunori Hoshiya; Makiko Hoshiya; Trinh T Tran; Jennifer L Carey; Antonia E Stephen; David T MacLaughlin; Patricia K Donahoe; Shyamala Maheswaran
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-02       Impact factor: 11.205

6.  Induction of WNT inhibitory factor 1 expression by Müllerian inhibiting substance/antiMullerian hormone in the Müllerian duct mesenchyme is linked to Müllerian duct regression.

Authors:  Joo Hyun Park; Yoshihiro Tanaka; Nelson A Arango; Lihua Zhang; L Andrew Benedict; Mi In Roh; Patricia K Donahoe; Jose M Teixeira
Journal:  Dev Biol       Date:  2013-12-19       Impact factor: 3.582

7.  Novel role for anti-Müllerian hormone in the regulation of GnRH neuron excitability and hormone secretion.

Authors:  Irene Cimino; Filippo Casoni; Xinhuai Liu; Andrea Messina; Jyoti Parkash; Soazik P Jamin; Sophie Catteau-Jonard; Francis Collier; Marc Baroncini; Didier Dewailly; Pascal Pigny; Mel Prescott; Rebecca Campbell; Allan E Herbison; Vincent Prevot; Paolo Giacobini
Journal:  Nat Commun       Date:  2016-01-12       Impact factor: 14.919

8.  Relative levels of the proprotein and cleavage-activated form of circulating human anti-Müllerian hormone are sexually dimorphic and variable during the life cycle.

Authors:  Michael W Pankhurst; Yih Harng Chong; Ian S McLennan
Journal:  Physiol Rep       Date:  2016-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.